Walgreens Boots Alliance reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state.
Teva Pharm expects U.S. opioid case settlements to cost $2.6 billionAnalysts, Blockbusters, Business, Europe, Florida, Generics, Legal, Multiple Sclerosis, North America, Opioid Epidemic, Opioid Litigation, Quarterly results, Rhode Island, Sales, San Francisco, Settlements, Shares, Teva, Therapeutics, West Virginia
Teva Pharmaceutical Industries believes the company would have to pay around $2.6 billion in cash and medicine to settle thousands of lawsuits alleging the world’s largest generic firm and other drug manufacturers fueled the U.S. opioid epidemic.
Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against EndoBusiness, Class Action Lawsuits, Endo, Lawsuits, Litigation, Opioid Litigation, Opioid Litigation, Opioid Overdoses, Opioid Prescriptions, Opioids, Opioids, Opioids, Opioids, Opioids, Overdoses, Overturned Verdicts, Prescriptions, Probes, Specialty Pharma, Substance Abuse, Tennessee, Therapeutics, U.S. Opioid Crisis
Endo International plc announced that the Tennessee Court of Appeals reversed a trial court judge’s order denying a motion for recusal by Endo’s wholly owned subsidiaries Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. in Clay County et al. v. Purdue Pharma, L.P., et al, pending in the Circuit Court for Cumberland County, Tennessee, and remanded the case for transfer to a different judge.
Members of the Sackler family who own Purdue Pharma LP are nearing an agreement to boost their more than $4 billion offer to resolve sprawling opioid litigation after negotiating with states that had objected to terms of the OxyContin maker’s bankruptcy reorganization, according to a court filing.
A U.S. judge said on Sept. 1 he would approve OxyContin maker Purdue Pharma LP’s bankruptcy reorganization plan, clearing a path to resolve thousands of opioid lawsuits and shielding the company’s wealthy Sackler family owners from future opioid litigation.
Endo International Plc agreed to pay $35 million to settle a lawsuit by Tennessee local governments and on behalf of a child allegedly born addicted to painkillers accusing the drugmaker of fueling the opioid epidemic, the company announced July 22.
Fifteen more states reached an agreement with Purdue Pharma LP and members of its wealthy Sackler family owners that moved the OxyContin maker a step closer to resolving widespread opioid litigation and exiting bankruptcy protection.
Drug companies to face first opioid trial following pandemic delaysAbbVie, AmerisourceBergen, Business, California, Cardinal Health, Coronavirus Disease (COVID-19) Pandemic, Drug Distributors, Johnson & Johnson, Legal, McKesson, Oklahoma, Opioid Litigation, Overdose Deaths, Teva, U.S. Centers for Disease Control and Prevention, U.S. Opioid Crisis
Four drugmakers, including Johnson & Johnson and Teva Pharmaceutical Industries Ltd., will go to trial on April 19 over claims they helped fuel an opioid crisis that has resulted in nearly 500,000 overdose deaths in the United States.
U.S. states are seeking a combined $26.4 billion from three major drug distributors and Johnson & Johnson to settle opioid litigation against the companies, the Wall Street Journal reported, citing people familiar with the matter.
Mallinckrodt receives SEC subpoena over Acthar gel lawsuitAddictions, Business, Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services (HHS), Gels, Generics, Infantile Spasms, Lawsuits, Manufacturing, Multiple Sclerosis, Opioid Litigation, Opioids, Shares, U.S. Securities and Exchange Commission (SEC)
Mallinckrodt Plc received a subpoena from the U.S. Securities and Exchange Commission for documents related to the drugmaker’s lawsuit against the U.S. Department of Health and Human Services (HHS).